Our results indicate that rTMS reduces inflammation-related gene expression (IL1β, TNFα, MMP9, and TGFβ), as suggested using a pulsed electromagnetic field following ischemia (Pena-Philippides et al., 2014). The gene discussed is TGFB1; the disease is ischemia.